Herpes simplex virus type 1 (HSV-1) establishes life-long latent
infection in sensory neurones, making it an ideal gene therapy vector to
target neuronal cells. To study retrograde transport of HSV-1, capsid
and tegument proteins were tested for interactions with the motor
cytoplasmic dynein, using a yeast two-hybrid system and in vitro pull
down assays. A strong interaction was demonstrated between the HSV-1
outer capsid protein VP26 (UL35) and the homologous 14 kDa dynein light
chains RP3 and Tctex1. The functional importance of VP26 for retrograde
transport was confirmed by microinjecting recombinant HSV-1 capsids into
living cells. Capsids containing VP26 moved closer to the cell nucleus,
while capsids without VP26 remained in a random distribution. Our
results suggest that the HSV-1 outer capsid protein VP26 mediates
binding of incoming capsids to the retrograde motor cytoplasmic dynein
during cellular infection, through interactions with dynein light
chains. It is hoped that these findings will help in the development of
a synthetic viral vector, which may allow targeted gene therapy in
patients with neurological diseases.